National Health Investors (NYSE:NHI) Downgraded by Zacks Investment Research to “Sell”

Zacks Investment Research cut shares of National Health Investors (NYSE:NHI) from a hold rating to a sell rating in a report released on Wednesday morning, Zacks.com reports.

According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “

Separately, ValuEngine downgraded National Health Investors from a hold rating to a sell rating in a report on Wednesday, October 2nd. Four equities research analysts have rated the stock with a sell rating and two have assigned a hold rating to the stock. The stock has an average rating of Sell and a consensus price target of $79.60.

NYSE NHI traded down $0.04 on Wednesday, reaching $82.80. The company’s stock had a trading volume of 177,557 shares, compared to its average volume of 202,311. The firm’s 50 day moving average is $82.86 and its two-hundred day moving average is $79.73. The company has a debt-to-equity ratio of 1.04, a quick ratio of 14.42 and a current ratio of 14.42. The stock has a market cap of $3.59 billion, a PE ratio of 15.11, a PEG ratio of 3.78 and a beta of 0.29. National Health Investors has a twelve month low of $70.54 and a twelve month high of $84.75.

National Health Investors (NYSE:NHI) last posted its quarterly earnings data on Thursday, August 8th. The real estate investment trust reported $0.92 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.37 by ($0.45). The company had revenue of $78.10 million for the quarter, compared to analyst estimates of $77.64 million. National Health Investors had a return on equity of 11.00% and a net margin of 50.71%. National Health Investors’s quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.38 EPS. Equities research analysts anticipate that National Health Investors will post 5.49 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 8th. Investors of record on Monday, September 30th will be issued a $1.05 dividend. The ex-dividend date of this dividend is Friday, September 27th. This represents a $4.20 dividend on an annualized basis and a yield of 5.07%. National Health Investors’s dividend payout ratio is currently 76.64%.

In other National Health Investors news, CIO Kevin Carlton Pascoe sold 900 shares of the company’s stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $82.46, for a total transaction of $74,214.00. Following the completion of the sale, the executive now owns 27,826 shares of the company’s stock, valued at $2,294,531.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 5.11% of the stock is owned by corporate insiders.

Institutional investors and hedge funds have recently bought and sold shares of the company. Lee Danner & Bass Inc. raised its stake in shares of National Health Investors by 0.6% in the second quarter. Lee Danner & Bass Inc. now owns 139,982 shares of the real estate investment trust’s stock valued at $10,923,000 after purchasing an additional 800 shares in the last quarter. Rudd International Inc. acquired a new position in shares of National Health Investors in the second quarter valued at $1,060,000. BlackRock Inc. raised its stake in shares of National Health Investors by 0.5% in the first quarter. BlackRock Inc. now owns 4,238,190 shares of the real estate investment trust’s stock valued at $332,910,000 after purchasing an additional 21,764 shares in the last quarter. Cambridge Investment Research Advisors Inc. raised its stake in shares of National Health Investors by 6.8% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 7,947 shares of the real estate investment trust’s stock valued at $624,000 after purchasing an additional 507 shares in the last quarter. Finally, GSA Capital Partners LLP raised its stake in shares of National Health Investors by 94.8% in the second quarter. GSA Capital Partners LLP now owns 5,697 shares of the real estate investment trust’s stock valued at $445,000 after purchasing an additional 2,773 shares in the last quarter. 69.72% of the stock is owned by institutional investors.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Featured Article: What does an inverted yield curve signify?

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit